Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Rebecca B, Klisovic"'
Autor:
Anjali S. Advani, Anna Moseley, Kristen M. O'Dwyer, Brent L. Wood, Min Fang, Matthew J. Wieduwilt, Ibrahim Aldoss, Jae H. Park, Rebecca B. Klisovic, Maria R. Baer, Wendy Stock, Rupali R. Bhave, Megan Othus, Richard C. Harvey, Cheryl L. Willman, Mark R. Litzow, Richard M. Stone, Elad Sharon, Harry P. Erba
Publikováno v:
J Clin Oncol
PURPOSE Chemotherapy outcomes in older patients with Philadelphia (Ph) chromosome–negative B-acute lymphoblastic leukemia (ALL) are very poor. Here, we evaluated blinatumomab as induction and consolidation therapy followed by prednisone, vincristin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b948d77ebeed0170e969be6dbea741d9
https://doi.org/10.1200/jco.21.01766
https://doi.org/10.1200/jco.21.01766
Autor:
Alice S. Mims, Anjali Mishra, Shelley Orwick, James Blachly, Rebecca B. Klisovic, Ramiro Garzon, Alison R. Walker, Steven M. Devine, Katherine J. Walsh, Sumithira Vasu, Susan Whitman, Guido Marcucci, Daniel Jones, Nyla A. Heerema, Gerard Lozanski, Michael A. Caligiuri, Clara D. Bloomfield, John C. Byrd, Richard Piekarz, Michael R. Grever, William Blum
Publikováno v:
Haematologica, Vol 103, Iss 6 (2018)
KMT2A partial tandem duplication occurs in approximately 5–10% of patients with acute myeloid leukemia and is associated with adverse prognosis. KMT2A wild type is epigenetically silenced in KMT2A partial tandem duplication; re-expression can be in
Externí odkaz:
https://doaj.org/article/64600a7ff8504256962fa5545939c604
Autor:
Mark Winderlich, Sumeet Ambarkhane, Wolfram Brugger, Maren Dirnberger-Hertweck, Wing Hang Leung, Elias Jabbour, Rebecca B. Klisovic
Publikováno v:
Cancer. 127:4190-4197
BACKGROUND B-precursor cell acute lymphoblastic leukemia (B-ALL) in adults is an aggressive and challenging condition, and patients with relapsed/refractory (R/R) disease after allogeneic stem cell transplantation (SCT), or noncandidates for SCT, hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9c9064b6fc78df1ea4d223c39000df
https://doi.org/10.1002/cncr.33796
https://doi.org/10.1002/cncr.33796
Autor:
Rene Swanink, Lambert Busque, Patricia Martin Regueira, Satu Mustjoki, Rebecca B. Klisovic, Dominik Wolf, Joaquin Martinez-Lopez, Juan Carlos Hernández-Boluda, Kimmo Porkka, Jeffrey H. Lipton
Publikováno v:
Leukemia & Lymphoma. 62:2040-2043
Although treatment with tyrosine kinase inhibitors (TKIs) has dramatically improved outcomes for the majority of patients with chronic myeloid leukemia (CML), approximately 20–30% will require a ch...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be46f77b4bbaf846a60e482a25fb7ab4
https://doi.org/10.1080/10428194.2021.1889536
https://doi.org/10.1080/10428194.2021.1889536
Autor:
Ben L. Sanford, Martin S. Tallman, Richard F. Schlenk, Lucas J. Huebner, Jürgen Krauter, Hartmut Döhner, Maria Teresa Voso, Hubert Serve, Andrew H. Wei, Jorge Sierra, Bruno C. Medeiros, Dietger Niederwieser, Arnold Ganser, Insa Gathmann, Miguel A. Sanz, Joseph Brandwein, Rebecca B. Klisovic, Sergio Amadori, Christian Thiede, Thomas W. Prior, Richard A. Larson, Theo de Witte, Konstanze Döhner, Kristina Laumann, Richard Stone, Clara D. Bloomfield, Frederick R. Appelbaum, Guido Marcucci, Gerhard Ehninger, Ilene Galinsky, Susan Geyer, Sumithra J. Mandrekar
Publikováno v:
Leukemia, 35, 9, pp. 2539-2551
Leukemia, 35, 2539-2551
Leukemia
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Leukemia, 35, 2539-2551
Leukemia
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Contains fulltext : 237748.pdf (Publisher’s version ) (Closed access) The prospective randomized, placebo-controlled CALGB 10603/RATIFY trial (Alliance) demonstrated a statistically significant overall survival benefit from the addition of midostau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32dbedd4a3766d3bcd8c06c784eca412
https://doi.org/10.1038/s41375-021-01179-4
https://doi.org/10.1038/s41375-021-01179-4
Publikováno v:
Blood. 140:13202-13203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5448f9cb9c406f8d26665cc2515f6d34
https://doi.org/10.1182/blood-2022-162665
https://doi.org/10.1182/blood-2022-162665
Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol
Autor:
Drenna Waldrop-Valverde, Katherine A. Yeager, Bonnie Mowinski Jennings, Tamara A. Mason, Nisha Patel, Rebecca B. Klisovic, Sudeshna Paul, Emily Burns, Deborah Watkins Bruner
Publikováno v:
Res Nurs Health
Over a quarter of chemotherapy regimens now include oral agents. Individuals living with cancer are now responsible for administering this lifesaving therapy at home by taking every dose as prescribed. One type of oral chemotherapy, tyrosine kinase i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd484e874823e9ed9705aa5e36a78eb
https://doi.org/10.1002/nur.22069
https://doi.org/10.1002/nur.22069
Autor:
Mitch A. Phelps, William Blum, Sophia G. Liva, Rebecca B. Klisovic, Bhavana Bhatnagar, Christopher C. Coss, Jiang Wang, Guido Marcucci, Susan Geyer, Katherine Walsh, Ramiro Garzon, Qiuhong Zhao, Alison Walker
Publikováno v:
Leuk Lymphoma
This phase I trial sought to determine a biologically safe and effective dose of AR-42, a novel histone deacetylase inhibitor, which would lead to a doubling of miR-29b prior to decitabine administration. Thirteen patients with previously untreated o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8c0b303d5b593a7d481e7ba3befdc4
https://doi.org/10.1080/10428194.2020.1719095
https://doi.org/10.1080/10428194.2020.1719095
Autor:
William Blum, John C. Byrd, Sumithira Vasu, Gregory K. Behbehani, Rebecca B. Klisovic, Karilyn Larkin, Ramiro Garzon, Amy S. Ruppert, Alice S. Mims, Qiuhong Zhao, James S. Blachly, Shelley Orwick, Bhavana Bhatnagar, Christopher C. Oakes, Parvathi Ranganathan, Alison Walker
Publikováno v:
Leuk Lymphoma
Current treatment options for older and relapsed or refractory (R/R) acute myeloid leukemia (AML) patients are limited and represent an unmet need. Based on preclinical studies showing strong anti-leukemic effects in vivo, this phase I dose-escalatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33a744d6dcd3398c33feb19683dd8527
https://doi.org/10.1080/10428194.2019.1665664
https://doi.org/10.1080/10428194.2019.1665664
Autor:
Jason H. Mendler, Kati Maharry, Heiko Becker, Ann-Kathrin Eisfeld, Leigha Senter, Krzysztof Mrózek, Jessica Kohlschmidt, Klaus H. Metzeler, Sebastian Schwind, Susan P. Whitman, Jihane Khalife, Michael A. Caligiuri, Rebecca B. Klisovic, Joseph O. Moore, Thomas H. Carter, Guido Marcucci, Clara D. Bloomfield
Publikováno v:
Haematologica, Vol 98, Iss 8 (2013)
Externí odkaz:
https://doaj.org/article/74884b369e1c4b6c99f3a0b79add6408